Clinical Trial Update: A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders [Phase 4]

View source ↗

Summary

Phase 4 multicenter study evaluating whether switching from risperidone or paliperidone to aripiprazole improves sexual dysfunction and hyperprolactinemia in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)
• INVEGA (PALIPERIDONE)
• Risperdal (risperidone)

Snippet

Sponsor: Si Tianmei | Conditions: Sexual Dysfunction, Hyperprolactinemia | Phase 4 | Status: UNKNOWN